Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ongoing $3.5 billion…

When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like theyre standing on a dock watching…

1 May 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

(neu: Schlusskurs) CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca wird ein unerwartet starker Gewinnsprung zum Jahresstart durch…

CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca wird ein unerwartet starker Gewinnsprung zum Jahresstart durch eine drohende Millionenstrafe in China…

…

The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the…

The FTSE 100 crept into positive territory in early trade on Tuesday before turning marginally negative as investors digested a…

AstraZeneca shares fall as revenue miss tempers strong Q1 earnings…

Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.…

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and…

Für den AKTIONÄR ist klar: Künstliche Intelligenz (KI) wird auch in der Forschung und Entwicklung von Medikamenten mittel- bis langfristig…

Amid a bullish backdrop for the broader market, Tempus AI (NASDAQ: TEM) stock is posting big gains Wednesday. The companys…

Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain…

Tempus AI (NASDAQ:TEM) said on Wednesday it has signed multi-year strategic collaborations with AstraZeneca (AZN.L) and Pathos AI to co-develop…